Sato-Okabayashi, Y., Isoda, K., Heissig, B., Kadoguchi, T., Akita, K., Kitamura, K., . . . Daida, H. (2020). Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis. Int J Cardiol Heart Vasc.
Citação norma ChicagoSato-Okabayashi, Yayoi, Kikuo Isoda, Beate Heissig, Tomoyasu Kadoguchi, Koji Akita, Kenichi Kitamura, Kazunori Shimada, Koichi Hattori, and Hiroyuki Daida. "Low-dose Oral Cyclophosphamide Therapy Reduces Atherosclerosis Progression By Decreasing Inflammatory Cells in a Murine Model of Atherosclerosis." Int J Cardiol Heart Vasc 2020.
MLA citiranjeSato-Okabayashi, Yayoi, et al. "Low-dose Oral Cyclophosphamide Therapy Reduces Atherosclerosis Progression By Decreasing Inflammatory Cells in a Murine Model of Atherosclerosis." Int J Cardiol Heart Vasc 2020.